secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibikase Therapeutics, Inc. (IKT)
CIK:        0001750149
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001193125-24-194177
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Inhibikase shareholders approve warrant issuance for private placement
----------------------------------------------------------------------

- Special Meeting held Aug 5, 2024; single proposal approved with 3,579,141 votes for.
- Proposal: approve issuance of common stock purchase warrants under Nasdaq Listing Rule 5635(d).
- Against: 84,029 votes; abstentions: 85,025; no broker non-votes.
- Warrants relate to a private placement and a warrant inducement; no terms disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750149/000119312524194177/0001193125-24-194177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750149/000119312524194177/d874511d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-194177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer